Although statin therapy is associated with reduced stroke and mortality risk, some studies report that higher lipid levels are associated with improved outcomes following ischemic stroke.
Aims
We examined the association of hyperlipidemia (HLD) combined with statin therapy on all-cause mortality in stroke patients.
Methods
All stroke patients in the Greater Cincinnati Northern Kentucky region of ∼1.3 million were identified using ICD-9 discharge codes in 2005 and 2010. Stroke patients with and without HLD were categorized based on their reported statin use at baseline or discharge into three groups: no-HLD/no-statins, HLD/no-statins, and HLD/on-statins. Cox proportional hazards model was used to estimate the risk of mortality at 30 days, 1 year, and 3 years poststroke.
Results
Overall, 77% (2953) of the 3813 ischemic stroke patients were diagnosed with HLD and 72% (n = 2123) of those patients were on statin medications. The mean age was 70.0 ± 14.6 years, 56% were women, and 21% were black. In adjusted analyses, the HLD/no-statins group showed 35% (adjusted hazard ratio (aHR) = 0.65, 95% CI: 0.46–0.92), 27% (aHR = 0.73, 95% CI: 0.59–0.90), and 17% (aHR = 0.83, 95% CI: 0.70–0.97) reduced risk of mortality at 30 days, 1 year, and 3 years, respectively, poststroke, compared with no-HLD/no-statins group. The HLD/on-statins group showed an additional 17% significant survival benefit at 3 years poststroke compared with HLD/no-statins group.
Conclusions
A diagnosis of HLD in ischemic stroke patients is associated with reduced short- and long-term mortality, irrespective of statin use. Statin therapy is associated with significant, additional long-term survival benefit.
MihaylovaBEmbersonJBlackwellL. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet2012; 380: 581–590.
2.
StoneNJRobinsonJGLichtensteinAH. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation2014; 129: S1–S45.
3.
AmarencoPBogousslavskyJCallahanA. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med2006; 355: 549–559.
4.
AmarencoPGoldsteinLBSzarekM. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack – the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Stroke2007; 38: 3198–3204.
5.
TrialistsCT. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials. Lancet 2015; 385: 1397–1405.
6.
YaghiSElkindMS. Lipid control and beyond: current and future indications for statin therapy in stroke. Curr Treat Options Cardiovasc Med2016; 18: 1–15.
7.
MarkakiINilssonUKostulasKSjostrandC. High cholesterol levels are associated with improved long-term survival after acute ischemic stroke. J Stroke Cerebrovasc Dis2014; 23: e47–e53.
8.
KotonSMolshatzkiNBornsteinNMTanneD. Low cholesterol, statins and outcomes in patients with first-ever acute ischemic stroke. Cerebrovasc Dis2011; 34: 213–220.
9.
OlsenTSChristensenRHBKammersgaardLPAndersenKK. Higher total serum cholesterol levels are associated with less severe strokes and lower all-cause mortality – Ten-year follow-up of ischemic strokes in the Copenhagen Stroke Study. Stroke2007; 38: 2646–2651.
10.
TuttolomondoADi RaimondoDDi SciaccaR. Effects of clinical and laboratory variables at admission and of in-hospital treatment with cardiovascular drugs on short term prognosis of ischemic stroke. The GIFA study. Nutr Metab Cardiovasc Dis2013; 23: 642–649.
11.
VautheyCde FreitasGRvan MelleGDevuystGBogousslavskyJ. Better outcome after stroke with higher serum cholesterol levels. Neurology2000; 54: 1944–1948.
12.
ZulianiGCherubiniAAttiAR. Low cholesterol levels are associated with short-term mortality in older patients with ischemic stroke. J Gerontol A Biol Sci Med Sci2004; 59: 293–297.
13.
DykerAGWeirCJLeesKR. Influence of cholesterol on survival after stroke: retrospective study. BMJ1997; 314: 1584.
14.
LiWLiuMWuBLiuHWangLCTanS. Serum lipid levels and 3-month prognosis in Chinese patients with acute stroke. Adv Ther2008; 25: 329–341.
15.
Cuadrado-GodiaEJiménez-CondeJOisARodríguez-CampelloAGarcia-RamalloERoquerJ. Sex differences in the prognostic value of the lipid profile after the first ischemic stroke. J Neurol2009; 256: 989–995.
16.
PanSLLienINChenTH. Is higher serum total cholesterol level associated with better long-term functional outcomes after noncardioembolic ischemic stroke?Arch Phys Med Rehabil2010; 91: 913–918.
17.
MizrahiEHWaitzmanAAradMAdunskyA. Functional outcome of elderly survivors of ischemic stroke: a retrospective study comparing non-hypercholesterolemic and hypercholesterolemic patients. Isr Med Assoc J2011; 13: 295–299.
18.
ZhaoWAnZHongY. Low total cholesterol level is the independent predictor of poor outcomes in patients with acute ischemic stroke: a hospital-based prospective study. BMC Neurol2016; 16: 1.
19.
BroderickJBrottTKothariR. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke1998; 29: 415–421.
20.
KisselaBSchneiderAKleindorferD. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke2004; 35: 426–431.
21.
KleindorferDOKhouryJMoomawCJ. Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke2010; 41: 1326–1331.
22.
LindsellCJAlwellKMoomawCJ. Validity of a retrospective National Institutes of Health Stroke Scale scoring methodology in patients with severe stroke. J Stroke Cerebrovasc Dis2005; 14: 281–283.
23.
WilliamsLSYilmazEYLopez-YunezAM. Retrospective assessment of initial stroke severity with the NIH stroke scale. Stroke2000; 31: 858–862.
24.
National Institutes of Health, National Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults; the evidence report. Obes Res 1998; 6(suppl 2): 51–209S.
25.
Aboa-EbouleCBinquetCJacquinA. Effect of previous statin therapy on severity and outcome in ischemic stroke patients: a population-based study. J Neurol2013; 260: 8.
26.
ArboixAGarcia-ErolesLOliveresMTargaCBalcellsMMassonsJ. Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia?BMC Neurol2010; 10: 47.
27.
FlintACKamelHNaviBB. Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival. Stroke2012; 43: 147–154.
28.
Ni ChroininDAsplundKAsbergS. Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials. Stroke2013; 44: 448–456.
29.
Ni ChroininDCallalyELDugganJ. Association between acute statin therapy, survival, and improved functional outcome after ischemic stroke: the North Dublin Population Stroke Study. Stroke2011; 42: 1021–1029.
30.
TrialistsCT. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet2012; 380: 581–590.
31.
ChenJLZhangZGLiY. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol2003; 53: 743–751.
32.
Di NapoliRTaccardiAAOliverMDe CaterinaR. Statins and stroke: evidence for cholesterol-independent effects. Eur Heart J2002; 23: 1908–1921.
NicholasJSSwearingenCJThomasJCRumboldtZTumminelloPPatelSJ. The effect of statin pretreatment on infarct volume in ischemic stroke. Neuroepidemiology2008; 31: 48–56.
35.
ShookSJGuptaRVoraNATievskyALKatzanIKriegerDW. Statin use is independently associated with smaller infarct volume in nonlacunar MCA territory stroke. J Neuroimaging2006; 16: 341–346.
36.
VatasseryGTSmithWEQuachHTLaiJCK. in-vitro oxidation of vitamin-E, vitamin-C, thiols and cholesterol in rat-brain mitochondria incubated with free-radicals. Neurochem Int1995; 26: 527–535.
37.
XiLGhoshSWangXYDasAAndersonFPKukrejaRC. Hypercholesterolemia enhances tolerance to lethal systemic hypoxia in middle-aged mice: possible role of VEGF downregulation in brain. Mol Cell Biochem2006; 291: 205–211.
